Literature DB >> 18063023

Ebolavirus and Marburgvirus: insight the Filoviridae family.

Paolo Ascenzi1, Alessio Bocedi, Julia Heptonstall, Maria Rosaria Capobianchi, Antonino Di Caro, Eloise Mastrangelo, Martino Bolognesi, Giuseppe Ippolito.   

Abstract

Ebolavirus and Marburgvirus (belonging to the Filoviridae family) emerged four decades ago and cause epidemics of haemorrhagic fever with high case-fatality rates. The genome of filoviruses encodes seven proteins. No significant homology is observed between filovirus proteins and any known macromolecule. Moreover, Marburgvirus and Ebolavirus show significant differences in protein homology. The natural maintenance cycle of filoviruses is unknown, the natural reservoir, the mode of transmission, the epidemic disease generation, and temporal dynamics are unclear. Lastly, Ebolavirus and Marburgvirus are considered as potential biological weapons. Vaccine appears the unique therapeutic frontier. Here, molecular and clinical aspects of filoviral haemorrhagic fevers are summarized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063023     DOI: 10.1016/j.mam.2007.09.005

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  37 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry.

Authors:  Maria V Yermolina; Jizhen Wang; Michael Caffrey; Lijun L Rong; Duncan J Wardrop
Journal:  J Med Chem       Date:  2011-01-04       Impact factor: 7.446

5.  A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system.

Authors:  Li Zhang; Qianqian Li; Qiang Liu; Weijin Huang; Jianhui Nie; Youchun Wang
Journal:  Hum Vaccin Immunother       Date:  2017-05-08       Impact factor: 3.452

6.  A new strategy for full-length Ebola virus glycoprotein expression in E.coli.

Authors:  Junjie Zai; Yinhua Yi; Han Xia; Bo Zhang; Zhiming Yuan
Journal:  Virol Sin       Date:  2016-12-16       Impact factor: 4.327

7.  Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.

Authors:  Ariel Sobarzo; Eddie Perelman; Allison Groseth; Olga Dolnik; Stephan Becker; Julius Julian Lutwama; John M Dye; Victoria Yavelsky; Leslie Lobel; Robert S Marks
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

8.  The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway.

Authors:  Nirupama Mulherkar; Matthijs Raaben; Juan Carlos de la Torre; Sean P Whelan; Kartik Chandran
Journal:  Virology       Date:  2011-09-09       Impact factor: 3.616

9.  Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

Authors:  Andrew S Herbert; Ana I Kuehne; James F Barth; Ramon A Ortiz; Donald K Nichols; Samantha E Zak; Spencer W Stonier; Majidat A Muhammad; Russell R Bakken; Laura I Prugar; Gene G Olinger; Jennifer L Groebner; John S Lee; William D Pratt; Max Custer; Kurt I Kamrud; Jonathan F Smith; Mary Kate Hart; John M Dye
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.

Authors:  Natarajan Ayithan; Steven B Bradfute; Scott M Anthony; Kelly S Stuthman; John M Dye; Sina Bavari; Mike Bray; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2013-10-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.